Guidant gets US nod for heart failure device products
This article was originally published in Clinica
Executive Summary
Guidant has gained US market approval for three new products designed to help physicians perform faster and more predictable implants of its cardiac resynchronisation therapy systems by facilitating access to the left side of the heart.